DIECI, Maria Vittoria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.394
EU - Europa 643
AS - Asia 241
AF - Africa 29
OC - Oceania 16
SA - Sud America 12
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.336
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.374
IT - Italia 273
CN - Cina 92
FR - Francia 67
DE - Germania 43
RU - Federazione Russa 40
GB - Regno Unito 34
IN - India 32
CZ - Repubblica Ceca 28
NL - Olanda 26
SE - Svezia 16
VN - Vietnam 16
AU - Australia 15
CA - Canada 13
ID - Indonesia 13
MK - Macedonia 12
PL - Polonia 12
UA - Ucraina 12
JP - Giappone 10
RO - Romania 10
ES - Italia 9
IQ - Iraq 9
AE - Emirati Arabi Uniti 8
ZA - Sudafrica 8
FI - Finlandia 7
HK - Hong Kong 7
HU - Ungheria 7
IE - Irlanda 7
MX - Messico 7
PH - Filippine 7
PT - Portogallo 7
TR - Turchia 7
UZ - Uzbekistan 7
BA - Bosnia-Erzegovina 6
EG - Egitto 5
IR - Iran 5
LT - Lituania 5
LY - Libia 5
SA - Arabia Saudita 5
SY - Repubblica araba siriana 5
BE - Belgio 4
CH - Svizzera 4
KR - Corea 4
PE - Perù 4
TW - Taiwan 4
AR - Argentina 3
BR - Brasile 3
GR - Grecia 3
NG - Nigeria 3
AT - Austria 2
CY - Cipro 2
HR - Croazia 2
LB - Libano 2
ME - Montenegro 2
NO - Norvegia 2
UG - Uganda 2
YE - Yemen 2
CL - Cile 1
CO - Colombia 1
DK - Danimarca 1
DZ - Algeria 1
EU - Europa 1
KE - Kenya 1
LK - Sri Lanka 1
MA - Marocco 1
MY - Malesia 1
MZ - Mozambico 1
NZ - Nuova Zelanda 1
RS - Serbia 1
SG - Singapore 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TH - Thailandia 1
ZM - Zambia 1
Totale 2.336
Salva come PNG Salva come JPEG
Città #
Fairfield 221
Ashburn 137
Houston 102
Seattle 95
Woodbridge 82
Santa Cruz 74
Cambridge 72
Buffalo 52
Wilmington 50
Ann Arbor 42
Shanghai 40
Des Moines 36
Milan 27
San Diego 25
Columbus 22
Mountain View 20
Modena 18
Beijing 17
Boardman 15
Dong Ket 15
Stockholm 14
Chicago 13
Naaldwijk 13
Collegeville 11
Las Vegas 11
Pushkina 11
Rome 11
Los Angeles 10
Paris 10
Turin 9
University Park 9
Padova 8
Skopje 8
Dublin 7
Helsinki 7
Jakarta 7
Muizenberg 7
New York 7
Tashkent 7
London 6
Mumbai 6
Ottawa 6
Parsippany 6
Sarajevo 6
Southend 6
Toronto 6
Amsterdam 5
Boston 5
Melbourne 5
Osimo 5
Sassari 5
Bengaluru 4
Bucharest 4
Cagliari 4
Clearwater 4
Council Bluffs 4
Delhi 4
Falkenstein 4
Frankfurt am Main 4
Genoa 4
Lake Forest 4
Medan 4
Nanchang 4
Naples 4
Napoli 4
Newark 4
Portland 4
Reggio Emilia 4
San Francisco 4
Torino 4
Tripoli 4
Verona 4
Bologna 3
Buenos Aires 3
Cairo 3
Cardiff 3
Central 3
Chandler 3
Debrecen 3
Dongguan 3
Fremont 3
Guangzhou 3
Istanbul 3
Lima 3
Mexico 3
Novara 3
Orléans 3
Osaka 3
Phoenix 3
Pittsburgh 3
Rochester 3
Scafati 3
Silver Spring 3
Taipei 3
Tarlac City 3
Trezzano Sul Naviglio 3
Zurich 3
Acireale 2
Ankara 2
Ankeny 2
Totale 1.574
Salva come PNG Salva come JPEG
Nome #
Rare breast cancer subtypes: Histological, molecular, and clinical peculiarities, file e31e124c-0965-987f-e053-3705fe0a095a 444
Survival analysis of the prospective randomized Cher-Lob study evaluating the dual anti-HER2 treatment with trastuzumab and lapatinib plus chemotherapy as neoadjuvant therapy for HER2-positive breast cancer, file e31e124e-be5a-987f-e053-3705fe0a095a 377
Comparison of HER-2 and hormone receptor expression in primary breast cancers and asynchronous paired metastases: impact on patient management, file e31e124d-7fd3-987f-e053-3705fe0a095a 312
Immune characterization of breast cancer metastases: prognostic implications., file e31e124d-5d08-987f-e053-3705fe0a095a 262
Validation of the AJCC prognostic stage for HER2-positive breast cancer in the ShortHER trial ., file e31e124d-cbc5-987f-e053-3705fe0a095a 195
Association of tumor-infiltrating lymphocytes with distant disease-free survival in the ShortHER randomized adjuvant trial for patients with early HER2+ breast cancer., file e31e124d-ce9b-987f-e053-3705fe0a095a 170
PIK3CA Mutation in the ShortHER Randomized Adjuvant Trial for Patients with Early HER2þ Breast Cancer: Association with Prognosis and Integration with PAM50 Subtype., file e31e124e-7356-987f-e053-3705fe0a095a 142
Trastuzumab-lapatinib as neoadjuvant therapy for HER2-positive early breast cancer: Survival analyses of the CHER-Lob trial, file e31e124f-ec08-987f-e053-3705fe0a095a 110
Erratum to: Tumor-infiltrating lymphocytes and molecular response after neoadjuvant therapy for HR+/HER2− breast cancer: results from two prospective trials (Breast Cancer Research and Treatment, (2017), 163, 2, (295-302), 10.1007/s10549-017-4191-y), file e31e124e-a41a-987f-e053-3705fe0a095a 107
Immune microenvironment and intrinsic subtyping in hormone receptor-positive/HER2-negative breast cancer., file e31e124f-50a8-987f-e053-3705fe0a095a 81
Everolimus plus aromatase inhibitors as maintenance therapy after first-line chemotherapy: Final results of the phase III randomised MAIN-A (MAINtenance Afinitor) trial, file e31e1250-9101-987f-e053-3705fe0a095a 29
KI67 AS A PREDICTOR OF RESPONSE AND LONG TERM SURVIVAL IN HORMONE RECEPTOR POSITIVE/HER2 NEGATIVE BREAST CANCER PATIENTS TREATED WITH PREOPERATIVE CHEMOTHERAPY, file e31e124d-3704-987f-e053-3705fe0a095a 28
Survival analysis of the prospective randomized Cher-Lob study evaluating the dual anti-HER2 treatment with trastuzumab and lapatinib plus chemotherapy as neoadjuvant therapy for HER2-positive breast cancer (BC)., file e31e124e-7982-987f-e053-3705fe0a095a 28
PIK3CA MUTATIONS IN HER2-POSITIVE BREAST CANCER PATIENTS ENROLLED IN THE ADJUVANT RANDOMIZED SHORT-HER STUDY., file e31e124e-9724-987f-e053-3705fe0a095a 27
MANAGEMENT OF ADVANCED BREAST CANCER: HOW TO INTEGRATE SCIENTIFIC DATA AND CLINICAL JUDGMENT, file e31e124d-223a-987f-e053-3705fe0a095a 25
COMPARISON OF HER-2 STATUS IN PRIMARY BREAST CANCER AND METASTATIC SITES: RESULTS FROM A SINGLE INSTITUTION ANALYSIS, file e31e124d-3017-987f-e053-3705fe0a095a 22
Homologous recombination deficiency, RB-loss gene signatures, intrinsic subtype and response to neoadjuvant treatment in HR+/HER2- early breast cancer: a correlative analysis of two phase II trials, file ef346bce-a610-41e3-a74c-0757ab038fe2 11
Incorporating weekly carboplatin in anthracycline and paclitaxel-containing neoadjuvant chemotherapy for triple-negative breast cancer: propensity-score matching analysis and TIL evaluation, file a55a95ed-a644-43ce-83fb-ca95f8a7a816 8
Pattern of distant relapse according to intrinsic molecular subtype in patients with HER2-positive breast cancer: a combined analysis of ShortHER, CherLOB, and two institutional cohorts, file bf213bec-1647-46b0-a203-20d776629dcd 8
Correction: Incorporating weekly carboplatin in anthracycline and paclitaxel-containing neoadjuvant chemotherapy for triple-negative breast cancer: propensity-score matching analysis and TIL evaluation (British Journal of Cancer, (2023), 128, 2, (266-274), 10.1038/s41416-022-02050-8), file a7fa9036-72cf-4643-8755-86cf7636b2d5 6
Metastatic site patterns by intrinsic subtype and HER2DX in early HER2-positive breast cancer, file bf72d498-4ba6-4382-82de-2349677bd250 3
Quantitative expression of estrogen receptor on relapse biopsy for ER-positive breast cancer: prognostic impact, file e31e124c-0494-987f-e053-3705fe0a095a 2
A prognostic model based on residual cancer burden and tumor-infiltrating lymphocytes on residual disease after neoadjuvant therapy in HER2+ breast cancer, file 4a2ea6ec-773e-4970-9e24-2fb8547e5f2d 1
Magnetic Resonance Imaging and Ultrasonography in Predicting Infiltrating Residual Disease after Preoperative Chemotherapy in Stage II-III Breast Cancer, file e31e124a-af0f-987f-e053-3705fe0a095a 1
Predictors of human epidermal growth factor receptor 2 fluorescence in-situ hybridisation amplification in immunohistochemistry score 2+ infiltrating breast cancer: a single institution analysis., file e31e124a-af9d-987f-e053-3705fe0a095a 1
Timing for starting second line therapy in recurrent ovarian cancer., file e31e124b-2ee2-987f-e053-3705fe0a095a 1
Discordance in receptor status between primary and recurrent breast cancer has a prognostic impact: a single Institution analysis, file e31e124b-3439-987f-e053-3705fe0a095a 1
Immunoglobulin G fragment C receptor polymorphisms and efficacy of preoperative chemotherapy plus trastuzumab and lapatinib in HER2-positive breast cancer, file e31e124c-03e8-987f-e053-3705fe0a095a 1
Anti-HER2 neoadjuvant and adjuvant therapies in HER2 positive breast cancer, file e31e124d-766b-987f-e053-3705fe0a095a 1
Totale 2.404
Salva come PNG Salva come JPEG
Categoria #
all - tutte 7.338
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.338
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201939 0 0 0 0 0 0 0 0 0 0 19 20
2019/2020252 11 12 9 18 24 27 35 31 27 18 24 16
2020/2021611 20 32 39 32 43 43 84 79 32 91 77 39
2021/2022580 58 56 75 41 45 25 33 26 32 33 99 57
2022/2023456 22 50 87 44 23 61 26 38 25 18 38 24
2023/2024376 13 30 28 28 38 32 54 37 29 24 63 0
Totale 2.404